Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α‐helical cationic antimicrobial peptides

In our previous study, we utilized a 26‐residue amphipathic α‐helical antimicrobial peptide L‐V13K (Chen et al., Antimicrob Agents Chemother 2007, 51, 1398–1406) as the framework to study the effects of peptide hydrophobicity on the mechanism of its antimicrobial action. In this study, we explored the effects of net charge and the number of positively charged residues on the hydrophilic/polar face of L‐V13K on its biological activity (antimicrobial and hemolytic) and biophysical properties (hydrophobicity, amphipathicity, helicity, and peptide self‐association). The net charge of V13K analogs at pH 7 varied between −5 and +10 and the number of positively charged residues varied from 1 to 10. The minimal inhibitory concentrations (MIC) against six strains of Pseudomonas aeruginosa as well as other gram‐negative and gram‐positive bacteria were determined along with the maximal peptide concentration that produces no hemolysis of human red blood cells (MHC). Our results show that the number of positively charged residues on the polar face and net charge are both important for both antimicrobial activity and hemolytic activity. The most dramatic observation is the sharp transition of hemolytic activity on increasing one positive charge on the polar face of V13K i.e., the change from +8 to +9 resulted in greater than 32‐fold increase in hemolytic activity (250 μg/ml to <7.8 μg/ml, respectively). © 2007 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 90: 369–383, 2008.

[1]  Alessandro Tossi,et al.  Amphipathic, α‐helical antimicrobial peptides , 2000 .

[2]  B. Holloway Genetic recombination in Pseudomonas aeruginosa. , 1955, Journal of general microbiology.

[3]  J. Fiddes,et al.  Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity , 1997, Antimicrobial agents and chemotherapy.

[4]  Robert E W Hancock,et al.  Comparison of Biophysical and Biologic Properties of α‐Helical Enantiomeric Antimicrobial Peptides , 2006, Chemical biology & drug design.

[5]  Tim J. Carver,et al.  The design of Jemboss: a graphical user interface to EMBOSS , 2003, Bioinform..

[6]  C. Mant,et al.  Temperature profiling of polypeptides in reversed-phase liquid chromatography. I. Monitoring of dimerization and unfolding of amphipathic alpha-helical peptides. , 2003, Journal of chromatography. A.

[7]  Xing Han,et al.  Sequence analysis and membrane partitioning energies of -helical antimicrobial peptides , 2004, Bioinform..

[8]  A. Waring,et al.  Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. , 2002, Protein engineering.

[9]  M. Pollack,et al.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections , 1977, Infection and immunity.

[10]  C. Mant,et al.  Role of Peptide Hydrophobicity in the Mechanism of Action of α-Helical Antimicrobial Peptides , 2006, Antimicrobial Agents and Chemotherapy.

[11]  Y. Shai,et al.  Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity. , 2002, Biochemistry.

[12]  G. Pierce Pseudomonas aeruginosa, Candida albicans, and device-related nosocomial infections: implications, trends, and potential approaches for control , 2005, Journal of Industrial Microbiology and Biotechnology.

[13]  R. Hancock,et al.  Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.

[14]  Darin L. Lee,et al.  Structure–activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S , 2003, Biopolymers.

[15]  F. Ausubel,et al.  Plants and animals share functionally common bacterial virulence factors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Mant,et al.  Preparative reversed-phase high-performance liquid chromatography collection efficiency for an antimicrobial peptide on columns of varying diameters (1mm to 9.4mm I.D.). , 2007, Journal of chromatography. A.

[17]  Robert E W Hancock,et al.  Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index* , 2005, Journal of Biological Chemistry.

[18]  Alessandro Tossi,et al.  Amphipathic α helical antimicrobial peptides. , 2001 .

[19]  C. Mant,et al.  Determination of intrinsic hydrophilicity/hydrophobicity of amino acid side chains in peptides in the absence of nearest-neighbor or conformational effects. , 2006, Biopolymers.

[20]  E. Krause,et al.  Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. , 1997, Biochemistry.

[21]  L. Frost,et al.  Composition and molecular weight of pili purified from Pseudomonas aeruginosa K , 1977, Journal of bacteriology.

[22]  David Eisenberg,et al.  The helical hydrophobic moment: a measure of the amphiphilicity of a helix , 1982, Nature.

[23]  I. A. Holder,et al.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. , 1975, The Journal of infectious diseases.

[24]  M. Vasil,et al.  Incidence of exotoxin production by Pseudomonas species , 1977, Infection and immunity.

[25]  H Lecar,et al.  Electrically gated ionic channels in lipid bilayers , 1977, Quarterly Reviews of Biophysics.

[26]  J. Dolan Temperature selectivity in reversed-phase high performance liquid chromatography. , 2002, Journal of chromatography. A.

[27]  Michael Bienert,et al.  Optimization of the antimicrobial activity of magainin peptides by modification of charge , 2001, FEBS letters.

[28]  Y. Shai,et al.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. , 1999, Biochimica et biophysica acta.

[29]  K. Holroyd,et al.  In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin , 1999, Antimicrobial Agents and Chemotherapy.

[30]  Darin L. Lee,et al.  A Novel Method to Measure Self-association of Small Amphipathic Molecules , 2003, Journal of Biological Chemistry.

[31]  R. Hancock,et al.  Cationic peptides: a new source of antibiotics. , 1998, Trends in biotechnology.

[32]  A. Tossi,et al.  Amphipathic alpha helical antimicrobial peptides: A systematic study of the effects of structural and physical properties on biological activity. , 2001 .

[33]  C. Kay,et al.  Dissociation and characterization of pilin isolated from Pseudomonas aeruginosa strains PAK and PAO. , 1982, Canadian journal of biochemistry.

[34]  Robert E. W. Hancock,et al.  Antimicrobial Peptide Therapeutics for Cystic Fibrosis , 2005, Antimicrobial Agents and Chemotherapy.

[35]  Katsumi Matsuzaki,et al.  Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity. , 2002, Biochemistry.

[36]  D. Phoenix,et al.  Amphiphilic α-Helical Antimicrobial Peptides and Their Structure / Function Relationships , 2005 .

[37]  R. Hancock,et al.  Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides , 1999, Infection and Immunity.

[38]  Y. Shai,et al.  Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. , 2000, Biochemistry.

[39]  C. Mant,et al.  Temperature profiling of polypeptides in reversed-phase liquid chromatography. II. Monitoring of folding and stability of two-stranded alpha-helical coiled-coils. , 2003, Journal of chromatography. A.

[40]  G. Arenas,et al.  Antimicrobial peptides: A natural alternative to chemical antibiotics and a potential for applied biotechnology , 2003 .